{"id":"https://openalex.org/W941675738","doi":null,"title":"Monthly versus PRN Ranibizumab for Neovascular AMD: A Randomized Phase 2 Open-Label Study","display_name":"Monthly versus PRN Ranibizumab for Neovascular AMD: A Randomized Phase 2 Open-Label Study","publication_year":2011,"publication_date":"2011-04-22","ids":{"openalex":"https://openalex.org/W941675738","mag":"941675738"},"language":"en","primary_location":{"id":"mag:941675738","doi":null,"is_oa":false,"landing_page_url":"https://iovs.arvojournals.org/article.aspx?articleid=2349645","pdf_url":null,"source":{"id":"https://openalex.org/S76304953","display_name":"Investigative Ophthalmology & Visual Science","issn_l":"0146-0404","issn":["0146-0404","1552-5783"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310321950","host_organization_name":"Cadmus Press","host_organization_lineage":["https://openalex.org/P4310321950"],"host_organization_lineage_names":["Cadmus Press"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Investigative Ophthalmology & Visual Science","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083264845","display_name":"Elijah Moon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093519","display_name":"Retina Macula Institute","ror":"https://ror.org/00gteb412","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210093519"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elijah Moon","raw_affiliation_strings":["Ophthalmology, Retina Macula Institute, Torrance, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ophthalmology, Retina Macula Institute, Torrance, California","institution_ids":["https://openalex.org/I4210093519"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112129750","display_name":"Mehran Taban","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093519","display_name":"Retina Macula Institute","ror":"https://ror.org/00gteb412","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210093519"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mehran Taban","raw_affiliation_strings":["Ophthalmology, Retina Macula Institute, Torrance, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ophthalmology, Retina Macula Institute, Torrance, California","institution_ids":["https://openalex.org/I4210093519"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051887271","display_name":"Ben Sharareh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093519","display_name":"Retina Macula Institute","ror":"https://ror.org/00gteb412","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210093519"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ben Sharareh","raw_affiliation_strings":["Ophthalmology, Retina Macula Institute, Torrance, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ophthalmology, Retina Macula Institute, Torrance, California","institution_ids":["https://openalex.org/I4210093519"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006481389","display_name":"Josh O. Wallsh","orcid":"https://orcid.org/0000-0002-1669-8939","observed_orcids":["https://orcid.org/0000-0002-1669-8939"]},"institutions":[{"id":"https://openalex.org/I4210093519","display_name":"Retina Macula Institute","ror":"https://ror.org/00gteb412","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210093519"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Josh Wallsh","raw_affiliation_strings":["Ophthalmology, Retina Macula Institute, Torrance, California"],"raw_orcid":"https://orcid.org/0000-0002-1669-8939","affiliations":[{"raw_affiliation_string":"Ophthalmology, Retina Macula Institute, Torrance, California","institution_ids":["https://openalex.org/I4210093519"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019578504","display_name":"Ron P. Gallemore","orcid":"https://orcid.org/0000-0002-6116-6026","observed_orcids":["https://orcid.org/0000-0002-6116-6026"]},"institutions":[{"id":"https://openalex.org/I4210093519","display_name":"Retina Macula Institute","ror":"https://ror.org/00gteb412","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210093519"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ron P. Gallemore","raw_affiliation_strings":["Ophthalmology, Retina Macula Institute, Torrance, California"],"raw_orcid":"https://orcid.org/0000-0002-6116-6026","affiliations":[{"raw_affiliation_string":"Ophthalmology, Retina Macula Institute, Torrance, California","institution_ids":["https://openalex.org/I4210093519"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210093519"],"apc_list":{"value":1850,"currency":"USD","value_usd":1850},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.07523453,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"52","issue":"14","first_page":"133","last_page":"133"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ranibizumab","display_name":"ranibizumab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/neovascular-age-related-macular-degeneration","display_name":"neovascular age-related macular degeneration","score":0.9959999918937683},{"id":"https://openalex.org/keywords/pro-re-nata-dosing","display_name":"pro re nata dosing","score":0.8740000128746033},{"id":"https://openalex.org/keywords/monthly-dosing","display_name":"monthly dosing","score":0.9120000004768372},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.953000009059906}],"concepts":[{"id":"https://openalex.org/C2781100027","wikidata":"https://www.wikidata.org/wiki/Q414270","display_name":"Ranibizumab","level":4,"score":0.6828498840332031},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6572473645210266},{"id":"https://openalex.org/C3019800554","wikidata":"https://www.wikidata.org/wiki/Q3813242","display_name":"Open label","level":3,"score":0.6416839957237244},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.592811644077301},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.2568887770175934},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12590304017066956},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.10057047009468079},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:941675738","doi":null,"is_oa":false,"landing_page_url":"https://iovs.arvojournals.org/article.aspx?articleid=2349645","pdf_url":null,"source":{"id":"https://openalex.org/S76304953","display_name":"Investigative Ophthalmology & Visual Science","issn_l":"0146-0404","issn":["0146-0404","1552-5783"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310321950","host_organization_name":"Cadmus Press","host_organization_lineage":["https://openalex.org/P4310321950"],"host_organization_lineage_names":["Cadmus Press"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Investigative Ophthalmology & Visual Science","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1180224996","https://openalex.org/W1011055810","https://openalex.org/W1431653411","https://openalex.org/W874530481","https://openalex.org/W2994362957","https://openalex.org/W932891388","https://openalex.org/W942657685","https://openalex.org/W2994365063","https://openalex.org/W1183885737","https://openalex.org/W989012018"],"abstract_inverted_index":null,"counts_by_year":[{"year":2017,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}